Physician profile
Weilin Liu
NPI 1700234747
$2,180.01
in general payments reported to CMS, 2019-2025
25 companies · $130 in 2025
The $130 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2020: $42.78 · 2021: $604 · 2022: $630 · 2023: $484 · 2024: $127 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $741.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $741.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $514.87 | 2021-2023 | Mounjaro, Jardiance |
| Astrazeneca Pharmaceuticals Lp | $266.41 | 2021-2024 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $256.07 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $145.20 | 2022-2023 | Nuzyra |
| Esperion Therapeutics, INC. | $140.70 | 2021 | |
| Bioventus LLC | $114.99 | 2025 | Exogen Ultrasound Bone Healing System, Durolane |
| Pfizer INC. | $109.00 | 2019 | |
| Amgen INC. | $67.12 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $63.14 | 2021 | |
| Novo Nordisk INC | $63.12 | 2019-2024 | |
| Kowa Pharmaceuticals America, INC. | $54.03 | 2021 | |
| Exact Sciences Corporation | $52.23 | 2023 | Cologuard Collection Kit |
| Biohaven Pharmaceuticals, INC. | $49.80 | 2021 | |
| Ucb, INC. | $37.02 | 2019 | |
| Glaxosmithkline, LLC. | $35.57 | 2022-2023 | Shingrix, Bexsero |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $31.61 | 2020-2021 | |
| Idorsia Pharmaceuticals US INC | $31.08 | 2023 | Quviviq |
| Abbott Laboratories | $24.78 | 2023 | Freestyle Libre 3 |
| Hologic Sales and Service, LLC | $24.05 | 2023 | Thinprep 2000 Processor, Aptima |
| Biohaven Pharmaceutical Holding Company Ltd. | $19.39 | 2022 | |
| Sanofi Pasteur INC. | $18.29 | 2023 | |
| Amarin Pharma, INC. | $16.80 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.04 | 2021 | |
| Cgg Medical INC | $14.84 | 2025 | |
| Daiichi Sankyo INC. | $13.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Weilin Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.